Impact of the Introduction of Rotavirus Vaccine on Hospital Admissions for Diarrhea Among Children in Kenya: A Controlled Interrupted Time-Series Analysis

BACKGROUND: Monovalent rotavirus vaccine, Rotarix (GlaxoSmithKline), was introduced in Kenya in July 2014 and is recommended to infants as oral doses at ages 6 and 10 weeks. A multisite study was established in 2 population-based surveillance sites to evaluate vaccine impact on the incidence of rota...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Clin Infect Dis
Autores principales: Otieno, Grieven P, Bottomley, Christian, Khagayi, Sammy, Adetifa, Ifedayo, Ngama, Mwanajuma, Omore, Richard, Ogwel, Billy, Owor, Betty E, Bigogo, Godfrey, Ochieng, John B, Onyango, Clayton, Juma, Jane, Mwenda, Jason, Tabu, Collins, Tate, Jacqueline E, Addo, Yaw, Britton, Tuck, Parashar, Umesh D, Breiman, Robert F, Verani, Jennifer R, Nokes, D James
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2020
Materias:
Articles and Commentaries
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7245159/
https://ncbi.nlm.nih.gov/pubmed/31544211
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciz912
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares